California-based Allez Health, formerly Zense-Life, announced it secured $60 million durante Series A+ financing.
The round was led by strategic investor Osang Healthcare, with participation from existing investors.
WHAT IT DOES
Allez Health is a continuous glucose monitoring biosensor platform that uses sensor technology to improve a patient’s risultato by analyzing datasets across various health afflictions.
The funding will be used to support operations and regulatory approval filings, scale manufacturing and accelerate clinical trials.
The company’s cofounders and comando team are made up of former Dexcom leaders.
Allez Health’s chief dirigente aziendale officer, Leif Bowman, was formerly senior director of marketing at Dexcom. Robert Boock, the company’s chief technology officer, was the lead inventor of Dexcom G4 CGM, and Ted Zhang, Allez Health’s chief science officer, led the development of Dexcom G4’s sensor membrane.
“We believe that person-centric health is critical for optimal health solutions,” Bowman said durante a statement. “We aim to bring to market a sensor that combines access, affordability, and reliable risultato because when it comes to an individual’s health, anzi che no one should have to choose between price and risultato.”
MARKET SNAPSHOT
Dexcom received clearance from the FDA durante March for its over-the-counter continuous glucose monitoring (CGM) solution .
Available without a prescription, the wearable biosensor boasts a battery life of up to two weeks and adheres to the back of the upper arm. The patch aids durante the detection of normal (euglycemic) and low high (dysglycemic) glucose levels.
A causa di February, Kakao Healthcare unveiled its latest version of an AI-enabled portatile diabetes management app called PASTA (Personalized, Accessible, Supportive, Tech-enabled, and Affordable). The app links to two CGM devices: CareSens Air by manufacturer i-SENS and Dexcom’s G7. The app also pairs with the Mallya smart cap for insulin pens.
